How to Sell a Mental Health Practice in 2026

Outpatient mental health has been one of the most actively consolidated corners of healthcare over the last five years. LifeStance went public, Refresh Mental Health sold to Optum, Mindpath Health raised from Leonard Green, and a long tail of regional platforms — Pathways, Discovery Behavioral Health, Thriveworks, Array Behavioral Care — are all on the hunt for add-ons. If you own a group practice with 10 or more clinicians, you have a real buyer universe. You just need to run the process correctly.

I've worked on mental health deals ranging from solo psychiatry practices to multi-state platforms, and the sellers who maximize value all do the same three things: they fix their credentialing before they go to market, they package their telehealth infrastructure as an asset, and they run a real process against multiple MSO and PE-backed buyers rather than taking the first call.

Who Actually Buys Mental Health Practices

The buyer landscape splits cleanly by practice size. Solo LCSWs and psychologists typically sell to other clinicians or simply wind down — there's almost no institutional market under $500K in revenue. Group practices with 5-15 clinicians sell to regional aggregators or PE-backed platforms at 4-6x EBITDA. Platforms with 30+ clinicians, multiple locations, and psychiatry mixed with therapy can command 8-12x EBITDA in a competitive process.

The premium buyers right now are MSOs (management services organizations) owned by private equity. They want turnkey add-ons — credentialed clinicians, clean payer contracts, working EHR, and ideally a W-2 employment model rather than 1099 contractors. Groups that are 100% 1099 get discounted 1-2 turns of EBITDA because the buyer assumes clinician attrition during integration.

Payer Credentialing Is the Deal

Nothing kills mental health deals faster than messy credentialing. Buyers run a payer-by-payer audit during diligence, and if they find expired contracts, lapsed CAQH profiles, or clinicians billing under the wrong NPI, your multiple drops immediately. I've seen a $12M deal re-traded by $2M because the seller's billing company had 14 clinicians out of network with BCBS for six months without anyone noticing.

Before you go to market, pull a credentialing report from every payer — Aetna, Cigna, UnitedHealthcare/Optum, BCBS, Humana, Medicare, and your state Medicaid plans. Document the effective date, contract rates, and re-credentialing deadline for every clinician at every payer. If you use a credentialing service like Medallion, Certify, or Verifiable, export the roster and reconcile it against payroll. The goal: when the buyer asks "are all your clinicians in network with all your major payers?", you can answer yes with documentation.

Commercial payer mix drives your multiple. A practice that's 80% commercial with $120-140 per session reimbursement sells at a premium. Practices heavy in Medicaid ($60-80 per session) trade at a discount unless they're large enough to be attractive to a Medicaid-focused platform like Brightline or Hazel Health.

Telehealth Infrastructure Is a Real Asset

Post-2020, every mental health buyer assumes telehealth is part of the practice. What they'll pay extra for is a telehealth platform that actually works. That means an integrated EHR and telehealth stack — typically SimplePractice, TheraNest, Valant, or Osmind — with measurement-based care tools, automated intake, insurance eligibility verification, and a functioning referral pipeline.

Document your telehealth utilization. Buyers want to see the split between in-person and virtual visits, no-show rates for each, and clinician productivity by modality. Practices where clinicians hit 28-32 billable hours per week on telehealth without burning out are the gold standard. If your telehealth no-show rate is under 8%, highlight it — the industry average is closer to 15%.

One caution: the DEA's telehealth prescribing rules for controlled substances are still evolving post-PHE. If you have psychiatrists prescribing Schedule II medications via telehealth, make sure your compliance posture is defensible. Buyers' lawyers will ask.

What Buyers Diligence in Mental Health Deals

Mental health diligence follows a predictable pattern. Expect the buyer to send a request list covering these areas:

• Clinician roster and productivity: licensure state, NPI, specialty, FTE status, weekly billable hours, panel size, tenure. Buyers want to see stable panels and low turnover.
• Payer contracts and rates: every contract, every fee schedule, every amendment. If you don't have copies, start pulling them now.
• Revenue cycle metrics: days in A/R, denial rate by payer, write-off rate, net collection rate. Healthy practices run 35-45 days in A/R and under 8% denials.
• Clinical compliance: treatment plan documentation, supervision notes for pre-licensed clinicians, audit history with any payer.
• 1099 vs W-2 structure: if you classify therapists as 1099, be ready to defend it. The Department of Labor has been aggressive here.

Running the Process

For practices with $1M+ in EBITDA, hire a healthcare-focused investment banker or M&A advisor. Generalist business brokers don't have the MSO relationships and rarely know how to position a behavioral health asset. Firms like Provident, Coker, Cross Keys, and VERTESS run mental health processes regularly.

A clean process takes 6-9 months: 4-6 weeks to prepare the confidential information memorandum, 4-6 weeks of buyer outreach and indications of interest, 6-8 weeks of management presentations and second-round bids, then 8-12 weeks of exclusive diligence and definitive agreement drafting. Get a quality of earnings report from a Big Four or top regional firm before you send your CIM — sell-side QofE pays for itself by eliminating the buyer's ability to re-trade on EBITDA adjustments.

Expect MSO deals to include an earnout or rollover equity component. A typical structure: 70-80% cash at close, 10-20% rollover into the platform's equity, and a 1-2 year earnout tied to clinician retention. Don't sign anything where 30%+ of your consideration is contingent — if the buyer won't pay you in cash, they don't believe their own growth story.

What to Fix Before You Go to Market

If you're 12-18 months from selling, here's the priority list:

Convert 1099 clinicians to W-2 where practical. It hurts near-term margin but adds 1-2 turns of EBITDA to your exit multiple. Buyers pay up for employed clinician models because retention risk is lower.

Clean up your EHR data. Make sure session notes are closed on time, diagnoses are coded correctly, and the data is exportable. Deals have died because the seller couldn't produce a clean clinician-level productivity report.

Diversify your payer mix. If one payer is more than 30% of your revenue, buyers see concentration risk. Add 1-2 new commercial contracts before going to market, even if the rates are marginal.

Build middle management. If you're the clinical director, billing manager, and HR all in one person, the practice doesn't function without you. Hire a practice administrator 12 months before the sale so the buyer sees operational independence.

The Bottom Line

The mental health M&A market is still active despite the broader healthcare slowdown, but buyers have gotten much more disciplined since 2022. The days of getting 12x EBITDA for a messy roll-up story are over. What still commands premium multiples: clean credentialing, W-2 clinicians, measurable telehealth productivity, diversified commercial payer mix, and a management team that can run the practice without the founder. Spend 12-18 months getting those right before you engage a banker, and you'll land in the top quartile of outcomes.